Quality Policy

 

Oncology Imaging Systems Limited is committed to an operating philosophy which is based on openness in communication, integrity in serving our customers and responsibility to the communities within which we operate. Our mission is to provide the best products and the best customer service, putting you and your patients in the best position. We have established our quality policy to be consistent with our company’s values and goals.​
 

Oncology Imaging Systems Limited operates a Quality Management System that has gained ISO 9001:2015 certification.

 

It is the company’s objective to ensure we understand our customers’ needs, meet their requirements and exceed their expectations. The management is committed to the enhancement of customer satisfaction through the implementation of the following:

 

  • Developing the Quality Management System

  • Continually improving the effectiveness of the Quality Management System

  • Monitoring quality performance and implementing improvements

 

Top management demonstrates leadership and commitment with respect to the Quality Management System by:

 

  • Ensuring that customer needs and expectations are determined and fulfilled with the aim of achieving customer satisfaction

  • Communicating the importance of meeting customer needs and all relevant statutory and regulatory requirements

  • Establishing the Quality Policy and setting Quality Objectives at relevant functions, levels and processes

  • Reporting on the internal audit results as a means of monitoring and measuring the processes and the effectiveness of the Quality Management System

  • Ensuring that the resources needed for the Quality Management System are available

  • Recognising and developing quality people and team excellence

  • Ensuring all personnel understand the requirements of this Quality Policy and abide with the contents of the Quality Management System.  

 

This policy is made available to all employees, external providers and other interested parties. The policy is regularly reviewed in order to ensure its continuing suitability. 

A signed copy of this statement is available on request.

 

PY01 | Rev B | Updated 27/04/2020 | Reviewed 04/01/2022